Notable increases were also seen in the Vyndaqel family and Eliquis revenues, driven by market expansion and increased adoption rates. Dr. Albert Bourla, Chairman and CEO of Pfizer, commented ...
5 days ago
Time Magazine
Albert Bourla
4 days ago
FierceBiotech
Pfizer plans to be 'very active' in obesity market, but CEO mum on precise R&D plans
Yahoo Finance via Yahoo
Pfizer stock gains 7% after earnings beat, company calls dividend 'secure'
Pharmaceutical Technology via Yahoo
Pfizer’s reported net income declines 44% in Q1 2024
Guru Focus
Q1 2024 Pfizer Inc Earnings Call Transcript
May 01, 2024 / 02:00PM GMTOperator Good day, everyone, and welcome to Pfizer's First Quarter 2024 Earnings Conference Call. Today's call is being recorded. At t
Reuters via Yahoo
Pfizer lifts profit forecast as CEO sees reason for optimism in 2024
Motley Fool via Yahoo
Why Pfizer Stock Blasted More Than 6% Higher Today
Forbes
Pfizer’s 44% Decline In Profits Still Tops Estimates—Stock Bounces From Decade Low
6 days ago
Investing.com
Pfizer stock climbs as first quarter earnings, revenue come ahead of estimates By Investing.com
View all
Greek-American pharmaceutical executive
Albert Bourla (born October 21, 1961) is an American-Greek veterinarian and the chairman and chief executive officer of Pfizer, an American pharmaceutical company. He joined the co... Wikipedia